Asymmetrical olfactory acuity and neuroleptic treatment in schizophrenia

Schizophrenia Research

Volumn 44, Issue 3, 2000, Pages 221-232

  Purdon , S E ^a   Flor Henry, P ^a  

^a ALBERTA HOSPITAL EDMONTON   (Canada)

Author keywords

Acuity; Asymmetry; Laterality; Neuroleptic; Olfaction; Schizophrenia; UPSIT

Indexed keywords

BENZATROPINE; BUTANOL; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; HEARING; HEMISPHERIC DOMINANCE; HUMAN; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCHIZOPHRENIA; SMELLING DISORDER; TACTILE DISCRIMINATION; TEMPORAL LOBE; TREATMENT OUTCOME; VISION;

ADULT; ANTIPSYCHOTIC AGENTS; DOUBLE-BLIND METHOD; FEMALE; FUNCTIONAL LATERALITY; HUMANS; MALE; OLFACTION DISORDERS; PROSPECTIVE STUDIES; SCHIZOPHRENIA; SENSORY THRESHOLDS; SMELL;

EID: 0034283776     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(99)00212-1     Document Type: Article

References (69)

1. Annett M. Hand preference and the laterality of cerebral speech. Cortex. 11:1975;305-328.
2. Beck A.T. Beck Depression Inventory Manual. 1987;Texas: Psychological Corporation, San Antonio.
3. Becker E., Hummel T., et al., Piel E. Olfactory event-related potentials in psychosis prone subjects. International Journal of Psychophysiology. 15:1993;51-58.
4. Bogerts B., Meertz E., Shonfeldt-Bausch R. Basal ganglia and limbic system pathology in schizophrenia. Archives of General Psychiatry. 42:1985;784-791.
5. Bracha H.S. Asymmetric rotational (circling) behaviour, a dopamine related asymmetry: preliminary findings in unmedicated and never medicated schizophrenic patients. Biological Psychiatry. 22:1987;995-1003.
6. Bradley E.A. Olfactory acuity to a pheromonal substance and psychotic illness. Biological Psychiatry. 91:1984;899-905.
7. Brewer W.J., Edwards J., Anderson V., Robinson T., Pantelis C. Neuropsychological olfactory, and hygiene deficits in men with negative symptom schizophrenia. Biological Psychiatry. 40:1996;1021-1031.
8. Bromley S.M., Doty R.L. Odor recognition memory is better under bilateral than unilateral test conditions. Cortex. 31:(1):1995;25-40.
9. Buchanan R.W., Strauss M.E., Kirkpatrick B., Holstein C., Breier A., Carpenter W.T. Jr. Neuropsychological impairments in deficit vs nondeficit forms of schizophrenia. Archives of General Psychiatry. 51:(10):1994;804-811.
10. Doty R.L. The Smell Identification Test Manual. 1983;Sensonics, Haddonfield, NJ.
11. Doty R.L., Genow A., Hummel T. Scratch density differentiates microsmic from normosmic and anosmic subjects on the University of Pennsylvania Smell Identification Test. Perceptual & Motor Skills. 86:1998;211-216.
12. Doty R.L., Shaman P., Dann M. Development of the University of Pennsylvania Smell Identification Test: A standardized microencapsulated test of olfactory function. Physiological Behavior. 32:1984;489-502.
13. Dunn T.P., Weller M.P. Olfaction in schizophrenia. Perceptual & Motor Skills. 69:(31):1989;833-834.
14. Early T.S., Haller J.W., Posner M.I., Raichle M. The left striato-pallidal hyperactivity model of schizophrenia. David A.S., Cutting J.C. The Neuropsychology of Schizophrenia. Brain Damage Behaviour and Cognition. 1994;15-37 Lawrence Erlbaum Associates Inc, England.
15. Flor-Henry P. Psychosis and temporal lobe epilepsy: A controlled investigation. Epilepsia. 10:1969;363-395.
16. Flor-Henry P. Mood, the right hemisphere and the implications of spatial information perceiving systems. Research Communications in Psychology Psychiatry and Behavior. 82:1983;143-170.
17. Goldberg T.E., Weinberger D.R. Methodological issues in the neuropsychological approach to schizophrenia. Nasrallah H.A., Weinberger D.R. Handbook of Schizophrenia: The Neurology of Schizophrenia. Vol. 1 :1986;141-156 Elsevier Science, Amsterdam.
18. Good K.P., Martzke J.S., Honer W.G., Kopala L.C. Left nostril olfactory identification impairment in a subgroup of male patients with schizophrenia. Schizophrenia Research. 33:(1-2):1998;35-43.
19. Gross-Isseroff R., Stoler M., Ophir D., Lancet D., Sirota P. Olfactory sensitivity to androstenone in schizophrenic patients. Biological Psychiatry. 22:1987;922-925.
20. Gruzelier J.H., Hammond N.V. Gains losses and lateral differences in the hearing of schizophrenic patients. British Journal of Psychology. 70:1979;319-330.
21. Hagger C., Buckley P., Kenny J.T., Friedman L., Ubogy D., Meltzer H. Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biological Psychiatry. 34:1993;702-712.
22. Harrow M., Yonan C.A., Sands J.R., Marengo J. Depression in schizophrenia: are neuroleptics akinesia or anhedonia involved? Schizophrenia Bulletin. 20:1994;327-338.
23. Henkin R.I. Drug-induced taste and smell disorders: Incidence mechanisms and management related primarily to treatment of sensory receptor dysfunction. Drug Safety. 11:1994;318-377.
24. Houlihan D.J., Flaum M., Arnold S.E., Keshavan M., Alliger R. Further evidence for olfactory identification deficits in schizophrenia. Schizophrenia Research. 12:(2):1994;179-182.
25. Hurwitz T., Kopala L., Clark C., Jones B. Olfactory deficits in schizophrenia. Biological Psychiatry. 23:1988;123-128.
26. Jerussi T.P., Taylor C.A. Bilateral asymmetry in striatal dopamine metabolism: implications for pharmacotherapy of schizophrenia. Brain Research. 246:1982;71-75.
27. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin. 13:1987;261-276.
28. Kopala L.C., Clark C., Hurwitz T. Olfactory deficits in neuroleptic naive patients with schizophrenia. Schizophrenia Research. 8:1992;245-250.
29. Kopala L., Clark C., Hurwitz T. Sex differences in olfactory function in schizophrenia. American Journal of Psychiatry. 641:1989;1320-1322.
30. Kopala L., Good K., Honer W.G. Olfactory hallucinations and olfactory identification ability in patients with schizophrenia and other psychiatric disorders. Schizophrenia Research. 21:1994;205-211.
31. Lidow M.S., Goldman-Rakic P.S. A common action of clozapine haloperidol and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex. Proceedings of the National Academy of Sciences of the United States of America. 91:1994;4353-4356.
32. Malaspina D., Perera G.M., Lignelli A., Marshall R.S., Esser P.D., Storer S., Furman V., Wray A.D., Coleman E., Gorman J.M., Van Heertum R.L. SPECT imaging of odor identification in schizophrenia. Psychiatry Research: Neuroimaging Section. 82:1998;53-61.
33. Malaspina D., Wray A.D., Friedman J.H., Amador X., Yale S., Hasan A., Gorman J.M., Kaufmann C.A. Odor discrimination deficits in schizophrenia: association with eye movement dysfunction. Journal of Neuropsychiatry & Clinical Neurosciences. 6:(3):1994;273-278.
34. Martinez B.A., de Cain W.S., Wijk R.A., Spencer D.D., Novelly R.A., Sass K.J. Olfactory functioning before and after resection for intractable seizures. Neuropsychology. 7:1993;351-363.
35. Martzke J.S., Kopala L.C., Good K.P. Olfactory dysfunction in neuropsychiatric disorders: Review and methodological considerations. Biological Psychiatry. 42:1997;721-732.
36. Myslobodsky M.S., Mintz M., Tomer R. Neuroleptic effects and the site of abnormality of schizophrenia. Myslobodsky M.S. Hemisyndromes: Psychobiology Neurology Psychiatry. 1983;388 Academic Press, New York.
37. Nordin S., Paulsen J.S., Murphy C. Sensory and memory-mediated olfactory dysfunction in Huntington's disease. Journal of the International Neuropsychological Society. 1:1995;281-290.
38. Norton R., Brown K., Howard R. Smoking, nicotine dose and the lateralisation of electrocortical activity. Psychopharmacology. 108:1992;473-479.
39. Nyberg S., Farde L., Halldin C. A PET study of 5-HT2 and D2 dopamine receptor occupancy induced by olanzapine in healthy subjects. Neuropsychopharmacology. 16:(1):1997;1-7.
40. Pasquali B. Menstrual phase, history of smoking and taste discrimination in young women. Perceptual & Motor Skills. 84:(32):1997;1243-1246.
41. Peacock L., Solgaard T., Lublin H., Gerlach J. Clozapine versus typical antipsychotics. A retro- and prospective study of extrapyramidal side effects. Psychopharmacology. 124:1996;188-196.
42. Pogun S., Demirgoren S., Pehlivan M., Aydin H. Tobacco smoking induced gender differences in interhemispheric processing. Domino E.F. Brain Imaging of Nicotine and Tobacco Smoking. 1995;310 NPP Books, Ann Arbor, MI.
43. Posner M.I., Early T.S., Reiman E., Pardo P.J., Dhawan M. Asymmetries in hemispheric control of attention in schizophrenia. Archives of General Psychiatry. 45:1988;814-821.
44. Purdon S.E. Cognitive improvement to Clozapine. Schizophrenia Research. 12:1996;148.
45. Purdon S.E. Olfactory identification and Stroop interference converge in schizophrenia. Journal of Psychiatry and Neuroscience. 23:(3):1998;163-171.
46. Purdon, S.E., Jones, B.D., Stip, E., Labelle, A., Addington, D., Breier, A., David, S., Tollefson, G., et al., in press. Neuropsychological change in early phase schizophrenia over twelve months of treatment with olanzapine risperidone or haloperidol. Archives of General Psychiatry.
47. Purdon S.E., Jones B., Stip E., Labelle A., Addington D., et al. New learning and memory over 12 months prospective treatment with olanzapine, risperidone, or haloperidol. Schizophrenia Research. 30:1999;239.
48. Purdon S.E., Mohr E., Ilivitsky V., Jones B.D.W. Huntington's disease: pathogenesis diagnosis and treatment. Journal of Psychiatry and Neuroscience. 19:1994;359-367.
49. Sakuma M., Hoff A.L., DeLisi L.E. Functional asymmetries in schizophrenia and their relationship to cognitive performance. Psychiatry Research. 65:1996;1-13.
50. Seidman L.J., Pepple J.R., Faraone S.V., Kremen W.S., Green A., Brown W.A., Tsuang M.T. Neuropsychological performance in chronic schizophrenia in response to neuroleptic dose reduction. Biological Psychiatry. 33:1993;574-584.
51. Seidman L.J., Talbot N.L., Kalinowski A.G., McCarley R.W., Faraone S.V., Kremen W.S., Pepple J.R., Tsuang M.T. Neuropsychological probes of fronto-limbic system dysfunction in schizophrenia: Olfactory identification and Wisconsin card sorting performance. Schizophrenia Research. 6:1992;55-65.
52. Serafetinedes E.A. Voltage laterality in the EEG of psychiatric patients. Diseases of the Nervous System. 34:1973;190-191.
53. Serby M., Larson P., Kalkstein D. Olfactory sense in psychoses. Biological Psychiatry. 82:1990;829-830.
54. Ship J.A., Weiffenbach J.M. Age, gender, medical treatment, and medication effects on smell identification. Journal of Gerontology. 48:(1):1993;M26-32.
55. Strauss M.E., Novakovic T., Tien A.Y., Bylsma F., Pearlson G.D. Disengagement of attention in schizophrenia. Psychiatry Research. 37:1991;139-146.
56. Suzuki H., Mori T., Kimura M., Endo S. Quantitative EEG characteristics of the state of depressive phase and the state of remission in major depression. Seishin Shinkeigaku Zasshi - Psychiatria et Neurologia Japonica. 98:1996;363-377.
57. Tan U., Gurgen F. Modulation of spinal motor asymmetry by neuroleptic medication of schizophrenia patients. International Journal of Neuroscience. 30:1986;165-172.
58. Thumfart W., Plattig K.H., Schlicht N. Smell and taste thresholds in older people - Review. Zeitschrift fur Gerontologie. 13:1980;158-188.
59. Tollefson G.D., Beasley C.M. Jr., Tran P.V., Street J.S., Krueger J.A., Tamura R.N., Graffeo K.A., Thieme M.E. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial [see comments]. American Journal of Psychiatry. 154:1997;457-465.
60. Tomer R. Asymmetrical effects of neuroleptics on psychotic patients' performance of a tactile discrimination task. Journal of Nervous & Mental Disease. 177:1989;699-700.
61. Tomer R., Flor-Henry P. Neuroleptics reverse attention asymmetries in schizophrenic patients. Biological Psychiatry. 25:1989;852-860.
62. Vierling J.S., Rock J. Variations in olfactory sensitivity to Exaltolide during the menstrual cycle. Journal of Applied Physiology. 22:1967;311-315.
63. Warner M.D., Peabody C.A., Csernansky J.G. Olfactory functioning in schizophrenia and depression. Biological Psychiatry. 72:1990;457-458.
64. Weiner H. External chemical messengers II - Natural history of schizophrenia. New York State Medical Journal. 76:1967;1144-1165.
65. Weiner H. External chemical messengers III - Mind and body in schizophrenia. New York State Medical Journal. 76:1967;1287-1311.
66. Wu J., Buchsbaum M.S., Moy K., Denlea N., Kesslak P., Tseng H., Plosnaj D., Heto M., Potkin S., Bracha S., Cotman C. Olfactory memory in unmedicated schizophrenics. Schizophrenia Research. 9:1993;41-47.
67. Youngentob S.L., Kurtz D.B., Leopold D.A., Mozell M.M., Hornung D.W. Olfactory sensitivity: Is there laterality? Chemical Senses. 7:1982;11-21.
68. Zatorre R.J., Jones-Gotman M. Right nostril advantage for discrimination of odors. Perception & Psychopsychics. 47:1990;526-531.
69. Zatorre R.J., Jones-Gotman M. Human olfactory discrimination after unilateral frontal or temporal lobectomy. Brain. 114:1991;71-84.